69 related articles for article (PubMed ID: 26112157)
1. Becatamide Found in Houttuynia cordata Suppresses P-selectin Expression Via Inhibiting COX Enzyme, Not Increasing cAMP in Platelets.
Park JB
Phytother Res; 2015 Sep; 29(9):1381-1387. PubMed ID: 26112157
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of veskamide, enferamide, becatamide, and oretamide on H2O2-induced apoptosis of PC-12 cells.
Park JB
Phytomedicine; 2011 Jul; 18(10):843-7. PubMed ID: 21377855
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, HPLC measurement and bioavailability of the phenolic amide amkamide.
Park JB
J Chromatogr Sci; 2014; 52(5):436-41. PubMed ID: 23712832
[TBL] [Abstract][Full Text] [Related]
4. Caffedymine from cocoa has COX inhibitory activity suppressing the expression of a platelet activation marker, P-selectin.
Park JB
J Agric Food Chem; 2007 Mar; 55(6):2171-5. PubMed ID: 17319684
[TBL] [Abstract][Full Text] [Related]
5. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of N-feruloyltyramine as the P-selectin expression suppressor from garlic (Allium sativum).
Park JB
J Agric Food Chem; 2009 Oct; 57(19):8868-72. PubMed ID: 19807156
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.
Libersan D; Rousseau G; Merhi Y
Thromb Haemost; 2003 Feb; 89(2):310-7. PubMed ID: 12574812
[TBL] [Abstract][Full Text] [Related]
10. 5-Caffeoylquinic acid and caffeic acid orally administered suppress P-selectin expression on mouse platelets.
Park JB
J Nutr Biochem; 2009 Oct; 20(10):800-5. PubMed ID: 18926684
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
12. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
[TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition.
Hoxha M; Buccellati C; Capra V; Garella D; Cena C; Rolando B; Fruttero R; Carnevali S; Sala A; Rovati GE; Bertinaria M
Pharmacol Res; 2016 Jan; 103():132-43. PubMed ID: 26621246
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
[TBL] [Abstract][Full Text] [Related]
15. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues.
Boulos C; Jiang H; Balazy M
J Pharmacol Exp Ther; 2000 Apr; 293(1):222-9. PubMed ID: 10734173
[TBL] [Abstract][Full Text] [Related]
16. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
17. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Thromb Res; 2009 Jun; 124(2):199-207. PubMed ID: 19327818
[TBL] [Abstract][Full Text] [Related]
18. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
19. Clovamide-type phenylpropenoic acid amides, N-coumaroyldopamine and N-caffeoyldopamine, inhibit platelet-leukocyte interactions via suppressing P-selectin expression.
Park JB; Schoene N
J Pharmacol Exp Ther; 2006 May; 317(2):813-9. PubMed ID: 16478826
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
